Regions :: North America :: Canada
Mitsubishi Tanabe Pharma to acquire Canadian biopharma company Medicago
9:22 AM MDT | July 15, 2013 | Natasha Alperowicz
Medicago (Quebec City, PQ), a biopharmaceutical company focused on developing vaccines based on proprietary manufacturing technologies, announced on Friday that it has entered into a definitive agreement with Mitsubishi Tanabe Pharma Corp. (MTPC; Osaka) whereby MTPC will acquire all of the issued and outstanding common shares of Medicago, other than the shares currently held by Philip Morris Investments (PMI; Bergen on Zoom, Netherlands), an affiliate of Philip Morris International and MTPC, for $1.16/share in cash or a maximum of C$179 million ($172.2...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee